Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Appoints R. Scott Greer to Board of Directors Feb 02, 2010 Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer Jan 12, 2010 Nektar Therapeutics Names Stephen K. Doberstein, Ph.D. Senior Vice President and Chief Scientific Officer Jan 06, 2010 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 06, 2010 Dennis Winger Joins Nektar Therapeutics' Board of Directors Dec 14, 2009 Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer Nov 30, 2009 Nektar Therapeutics Reports Third Quarter 2009 Financial Results Nov 04, 2009 Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets Oct 29, 2009 Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer Oct 28, 2009 Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego Oct 27, 2009 Pagination First page « first Previous page ‹ previous … Page 38 Page 39 Page 40 Page 41 Current page 42 Page 43 Page 44 Page 45 Page 46 … Next page next › Last page last »